National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$113.25
add to cart

Rights & Permissions

topleft topright

An Assessment of the Small Business Innovation Research Program at the National Institutes of Health (2009)

Citation Manager

. "3 SBIR Awards at NIH." An Assessment of the Small Business Innovation Research Program at the National Institutes of Health. Washington, DC: The National Academies Press, 2009.

Please select a format:

BibTeX EndNote RefMan


Page
77
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


An Assessment of the SBIR Program at the National Institutes of Health
FIGURE 3-23 Phase II use of PAs at NIH, 1998-2005.

FIGURE 3-23 Phase II use of PAs at NIH, 1998-2005.

SOURCE: National Institutes of Health.

BOX 3-1

A Note on Data

NIH data collection approaches presents some challenges for the purposes of this study. In principle, NIH collects data by award year—which means that each year of an award is separately identified within the database.

There are occasionally difficulties in connecting every award year of each award, as grant ID numbers can change, as do other possible connecting fields such as company name and award title.

As a result, we have for the purposes on this study developed approximations for award numbers and sizes. Numbers of Phase I awards are estimated by using the first year of SBIR support. Numbers of Phase II awards are estimated by using the second year of support where the award ID indicates that this is a Phase II award. Year two of Phase II support is estimated using year three of support where the award is Phase II, and year three of Phase II support is estimated using year four of support where the award is Phase II.

These estimates are undoubtedly not completely accurate. Where companies have received a second year of support during Phase I, the third year of support could be only the first year of Phase II support.

In a similar vein, we have generated estimates for average award size by adding the average for different years of Phase II support. It would facilitate future assessments if NIH would find ways to address these data difficulties as the agency refines its ongoing evaluation and assessment program.

Page
77